- Home
- HNRG vs KURA Comparison
HNRG vs KURA Comparison
Compare HNRG & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNRG
- KURA
- Stock Information
- Founded
- HNRG 1949
- KURA 2014
- Country
- HNRG United States
- KURA United States
- Employees
- HNRG N/A
- KURA N/A
- Industry
- HNRG Coal Mining
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HNRG Energy
- KURA Health Care
- Exchange
- HNRG Nasdaq
- KURA Nasdaq
- Market Cap
- HNRG 698.9M
- KURA 713.5M
- IPO Year
- HNRG N/A
- KURA N/A
- Fundamental
- Price
- HNRG $19.86
- KURA $10.28
- Analyst Decision
- HNRG Strong Buy
- KURA Buy
- Analyst Count
- HNRG 4
- KURA 14
- Target Price
- HNRG $20.00
- KURA $24.45
- AVG Volume (30 Days)
- HNRG 537.9K
- KURA 1.8M
- Earning Date
- HNRG 11-11-2025
- KURA 11-06-2025
- Dividend Yield
- HNRG N/A
- KURA N/A
- EPS Growth
- HNRG N/A
- KURA N/A
- EPS
- HNRG N/A
- KURA N/A
- Revenue
- HNRG $419,451,000.00
- KURA $83,279,000.00
- Revenue This Year
- HNRG $8.52
- KURA $68.63
- Revenue Next Year
- HNRG $4.46
- KURA $141.59
- P/E Ratio
- HNRG N/A
- KURA N/A
- Revenue Growth
- HNRG N/A
- KURA N/A
- 52 Week Low
- HNRG $8.13
- KURA $5.41
- 52 Week High
- HNRG $22.01
- KURA $19.73
- Technical
- Relative Strength Index (RSI)
- HNRG 58.78
- KURA 69.23
- Support Level
- HNRG $19.23
- KURA $9.48
- Resistance Level
- HNRG $20.03
- KURA $9.96
- Average True Range (ATR)
- HNRG 0.86
- KURA 0.41
- MACD
- HNRG -0.00
- KURA 0.06
- Stochastic Oscillator
- HNRG 62.63
- KURA 81.78
About HNRG Hallador Energy Company
Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.